• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

kyliem@unimelb.edu.au

Credentials


Position
Honorary Conjoint Principal Fellow
The Sir Peter MacCallum Department of Oncology
Education
Doctoral Degree (Research) / PhD
University of Melbourne
Bachelors Degree
University of Melbourne
ORCID

0000-0002-6238-4092

A/Prof Kylie Mason

Honorary Conjoint Principal Fellow
The Sir Peter MacCallum Department of Oncology

100 Scholarly works
4 Projects

HIGHLIGHTS

  • 2023

    Research grants (ARC, NHMRC, MRFF)

    Development of a Generalisable Evaluation Framework for High Upfront-Cost Therapies: Clinical, Economic, Ethico-Legal, Social and Cultural Considerations
  • 2022

    Research grants (ARC, NHMRC, MRFF)

    gEnomics4newborns: Integrating Ethics and Equity With Effectiveness and Economics for Genomic Newborn Screening
  • 2013

    Journal article

    ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
    DOI: 10.1038/nm.3048
  • 2011

    Journal article

    Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets
    DOI: 10.1182/blood-2011-04-347849
  • 2009

    Journal article

    Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function
    DOI: 10.1182/blood-2009-01-200345
  • 2009

    Journal article

    The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia
    DOI: 10.1038/leu.2009.151
  • 2008

    Journal article

    In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas
    DOI: 10.1073/pnas.0809957105
Kylie Mason

Latest Honours,
Awards and Fellowships


2004
Fellow of the Royal Australasian College of Physicians (FRACP)
2004
Fellow of the Royal College of Pathologists, Australia (FRCPA)

RECENT SCHOLARLY WORKS

  • 2026

    Journal article

    Management of hairy cell leukaemia in pregnancy
    DOI: 10.1177/1753495X251356377
  • 2025

    Journal article

    Economic burden of sickle cell disease in Australia
    DOI: 10.1111/imj.70092
  • 2025

    Journal article

    Methotrexate toxicity: the need for vigilance in prescribing and monitoring
    DOI: 10.1111/imj.70130
  • 2025

    Journal article

    Position statement on the management of pregnancy in sickle cell disease
    DOI: 10.1111/ajo.13888
  • 2025

    Journal article

    Routine magnetic resonance central nervous system imaging may be avoided in high-risk systemic diffuse large B-cell lymphoma with negative cerebrospinal fluid analyses
    DOI: 10.1080/10428194.2025.2451725
  • 2024

    Journal article

    Efficacy and Safety of Avatrombopag in Combination with Immunosuppressive Therapy in Treatment-Naïve Severe Aplastic Anemia: Results of the Diaamond-Ava-First Trial
    DOI: 10.1182/blood-2024-209378
  • 2024

    Journal article

    CD34-TdT-B-ALL masquerading as Burkitt lymphoma
    DOI: 10.1002/jha2.884
  • 2024

    Journal article

    Sickle cell disease in Australia: a snapshot from the Australian Haemoglobinopathy Registry
    DOI: 10.1111/imj.16297

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224